GLIOSARCOMA
Clinical trials for GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new GLIOSARCOMA trials appear
Sign up with your email to follow new studies for GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for aggressive brain tumors: immune therapy trial challenges standard care
Disease control CompletedThis study tested if a new type of treatment called immunotherapy could work better than standard chemotherapy for adults newly diagnosed with a specific, aggressive form of brain cancer (glioblastoma) that does not respond well to usual drugs. Patients received either the standa…
Matched conditions: GLIOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New brain cancer fight: adding Whole-Brain radiation to stop tumor return
Disease control CompletedThis study tested whether adding whole-brain radiation therapy and a drug called plerixafor to the standard treatment could better control an aggressive type of brain tumor called glioblastoma (GBM). It involved 21 adults who had recently been diagnosed and had surgery. The main …
Matched conditions: GLIOSARCOMA
Phase: PHASE2 • Sponsor: Lawrence D Recht • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists test second round of radiation for deadly brain cancer
Disease control CompletedThis study tested the safety of giving a second course of radiation to people whose aggressive brain tumor (glioblastoma) had grown back after initial treatment. The main goal was to find the highest dose of repeat radiation that patients could tolerate without severe side effect…
Matched conditions: GLIOSARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope in fight against deadly brain cancer: testing a powerful Immune-Boosting drug
Disease control CompletedThis study tested whether adding a new immunotherapy drug (atezolizumab) to the standard treatment of chemotherapy and radiation could help patients with newly diagnosed glioblastoma, a very aggressive brain cancer. The goal was to see if this combination was safe and if it could…
Matched conditions: GLIOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC